Table 3.
Treatment type characteristics
| Pre-pandemic period, n (%) N = 278 |
COVID-19 period, n (%) N = 340 |
p-value | |
|---|---|---|---|
| Primary surgical treatment | 157 (71) | 172 (75.4) | 0.337 |
| Primary surgical treatment in early stage (T1–T2) laryngeal cancer | 29 (80.5) | 40 (74) | 0.613 |
| Primary surgical treatment in early stage (T1–T2) oropharyngeal cancer | 9 (47.3) | 26 (86.6) | 0.001 |
| Palliative radiotherapy | 57 (20.5) | 112 (32.9) | 0.001 |
| Ineligible for treatment (best supportive care only) | 5 (1.8) | 21 (6.2) | 0.007 |